Related by context. Frequent words. (Click for all words.) 68 #mg/day [001] 68 serum uric acid 68 μg kg 67 lispro 67 fasting insulin 65 nonobese 64 creatine kinase 64 μg L 64 mmol l 64 μmol L 64 HbA 1c 64 glycemia 63 OGTT 63 plasma glucose 63 HbA1c levels 63 fasting glucose levels 63 serum glucose 63 diastolic BP 63 CI -#.# 63 elevated LDL cholesterol 63 serum concentrations 63 serum PSA 63 apolipoprotein B 62 Secondary endpoints include 62 glycated hemoglobin 62 glomerular filtration rate 62 lipid profiles 62 Cmax 62 total cholesterol LDL 62 p = .# [002] 62 Ramipril 62 metabolic parameters 62 fasting plasma glucose 62 mL kg 61 HbA1C 61 fasting blood glucose 61 confidence interval #.#-#.# 61 glyburide 61 lamotrigine 61 serum calcium 61 serum albumin 61 systolic BP 61 normotensive 61 glycosylated hemoglobin 60 serum sodium 60 mEq L 60 #mg/kg [002] 60 % CI #.#-#.# [003] 60 Secondary endpoints included 60 serum testosterone 60 magnesium intake 60 serum cholesterol 60 mg d 60 extrapyramidal symptoms 60 elevated blood glucose 60 cholesterol LDL C 60 prolactin levels 60 hypokalemia 60 1mg 59 elevated triglycerides 59 primary hypercholesterolemia 59 pg ml 59 ml min 59 leukopenia 59 nonsignificant 59 serum vitamin D 59 hypoglycemic events 59 lanthanum carbonate 59 NHANES III 59 nondiabetic 59 ng dL 59 mineral density 59 P = .# 59 hypertensives 59 tirofiban 59 hemoglobin concentration 58 placebo p = 58 hemoglobin A1C 58 serum phosphorus 58 creatinine levels 58 estimated glomerular filtration 58 CK MB 58 postop 58 CI #.#-#.# [002] 58 Pioglitazone 58 g dl 58 Dietary fiber 58 % CI #.#-#.# [007] 58 erythrocyte sedimentation rate 58 TAXUS p value 58 creatinine clearance 58 inactive placebo 58 nmol L 58 pharmacokinetic parameters 58 olmesartan 57 hypocalcemia 57 Secondary endpoints 57 left ventricular systolic 57 #mg dose [003] 57 RYGB 57 pramlintide